Evkeeza is the first medicine indicated for children in the EU as young as six months old to treat HoFH. Credit: FatCamera via Shutterstock. The
Periods of uncertainty test the resolve of even the most well-oiled medical device supply chains. If even one part or component suddenly becomes obsolete or
Amgen’s tarlatamab was also approved by the FDA for ES-SCLC last year. Image credit: Shutterstock / Marlon Trottmann. Amgen has said the UK’s Medicines and
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and
With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the heart failure (HF) market is expected to grow at
Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD exacerbations and pneumonia risk.
When Michael Adams was researching health insurance options in 2023, he had one very specific requirement: coverage for prosthetic limbs.
Identifying patterns in breast density changes can improve breast cancer risk prediction, emphasizing the importance of longitudinal assessments in screening.
Leveraging virus-free techniques and protocols, the research laboratories of ADSCC created the iPSCs. Credit: Abu Dhabi Stem Cells Center. The Abu Dhabi Stem Cells Center